TickerFactsScreenerDevelopers

International Stem Cell CORP (ISCO) — Operating Income

Annual figures by fiscal year, from SEC filings.

2010: -$10.46M2011: -$11.36M2012: -$9.81M2013: -$7.55M2014: -$8.68M2015: -$4.56M2016: -$4.85M2017: -$4.94M2018: -$3.47M2019: -$5.73M2020: -$2.82M2021: -$1.92M2022: -$183.0K2023: -$663.0K2024: -$68.0K2025: -$267.0K-$267.0K
2010Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$267.0K-292.6%
2024-$68.0K+89.7%
2023-$663.0K-262.3%
2022-$183.0K+90.5%
2021-$1.92M+31.8%
2020-$2.82M+50.8%
2019-$5.73M-64.9%
2018-$3.47M+29.7%
2017-$4.94M-1.9%
2016-$4.85M-6.3%
2015-$4.56M+47.4%
2014-$8.68M-15.0%
2013-$7.55M+23.1%
2012-$9.81M+13.6%
2011-$11.36M-8.5%
2010-$10.46M—